These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 8016003)
1. Cardioprotective therapeutics--drugs used in hypertension, hyperlipidaemia, thromboembolism, arrhythmias, the postmenopausal state and as anti-oxidants. Kendall MJ; Rajman I; Maxwell SR Postgrad Med J; 1994 May; 70(823):329-43. PubMed ID: 8016003 [No Abstract] [Full Text] [Related]
2. [Long-term drug prevention of cardiovascular diseases (methodological aspects)]. Metelitsa VI Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(2):103-7. PubMed ID: 6139116 [No Abstract] [Full Text] [Related]
4. [ALLHAT [Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial]]. Tomiyama H; Doba N Nihon Rinsho; 2001 Mar; 59 Suppl 3():393-7. PubMed ID: 11347101 [No Abstract] [Full Text] [Related]
5. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): practical implications. Oparil S Hypertension; 2003 May; 41(5):1006-9. PubMed ID: 12695423 [No Abstract] [Full Text] [Related]
6. [New cardiovascular-active drugs]. Bölter C Z Arztl Fortbild (Jena); 1984; 78(19):797-800. PubMed ID: 6506791 [No Abstract] [Full Text] [Related]
7. ALLHAT, or the soft science of the secondary end point. Neely DB Ann Intern Med; 2004 Jul; 141(1):77. PubMed ID: 15238380 [No Abstract] [Full Text] [Related]
9. Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research Group. Schrott HG; Bittner V; Vittinghoff E; Herrington DM; Hulley S JAMA; 1997 Apr 23-30; 277(16):1281-6. PubMed ID: 9109465 [TBL] [Abstract][Full Text] [Related]
10. [Primary prevention of coronary disease with drugs]. Capron L Rev Prat; 1998 Jun; 48(12):1281-2. PubMed ID: 9781183 [No Abstract] [Full Text] [Related]
11. Secondary prevention in coronary heart disease. Effects of statins have been in addition to those of aspirin and beta blockers. Morrell J BMJ; 1999 May; 318(7195):1419-20. PubMed ID: 10334767 [No Abstract] [Full Text] [Related]
12. A cardiologist's view of hormone replacement therapy and alternatives for cardioprotection. Wenger NK J Womens Health Gend Based Med; 2001 Apr; 10(3):257-60. PubMed ID: 11389785 [No Abstract] [Full Text] [Related]
13. Cost effectiveness of coronary heart disease prevention strategies in adults. Brown AD; Garber AM Pharmacoeconomics; 1998 Jul; 14(1):27-48. PubMed ID: 10182193 [TBL] [Abstract][Full Text] [Related]
14. Primary prevention of coronary heart disease in women. Rees M; Stevenson J; Menopause Int; 2008 Mar; 14(1):40-5. PubMed ID: 18380961 [TBL] [Abstract][Full Text] [Related]
15. Estrogen replacement therapy and coronary heart disease in postmenopausal women. King KM Health Care Women Int; 1996; 17(3):247-54. PubMed ID: 8852226 [TBL] [Abstract][Full Text] [Related]
16. Multiple septal coronary-cameral fistulae associated with paroxysmal atrial fibrillation. Işik T; Kurt M; Kaya A; Tanboğa IH Turk Kardiyol Dern Ars; 2012 Mar; 40(2):200. PubMed ID: 22710599 [No Abstract] [Full Text] [Related]
19. Most people don't take heart drugs as directed. Harv Mens Health Watch; 2012 Nov; 17(4):1, 8. PubMed ID: 23330206 [No Abstract] [Full Text] [Related]
20. [Cardiovascular effects of estrogen in postmenopausal women]. Zhu WL Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Aug; 24(4):409-12. PubMed ID: 12905664 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]